Table 2.
Univariate analysis |
Multivariate analysis |
|||
Variable | P value | Hazard ratio | 95% CI | P value |
Pathologc diagnosis | 0.000 | 0.000 | ||
CK19- HCC | ||||
CK19+ HCC | 3.055 | 1.235-7.558 | 0.016 | |
cHCC-CC | 4.588 | 1.953-10.781 | 0.000 | |
ICC | 6.986 | 2.997-16.284 | 0.000 | |
Age (yr) | 0.672 | |||
< 45 vs ≥ 45 | ||||
Gender | 0.197 | |||
Cirrhosis | 0.542 | |||
Tumor size (cm) | 0.000 | |||
< 5 vs ≥ 5 | ||||
Tumor number | 0.179 | |||
Single vs multiple | ||||
Satellite nodule | 0.001 | 1.997 | 1.010-3.949 | 0.047 |
Microvascular invasion | 0.005 | 2.884 | 1.491-5.581 | 0.002 |
Macrovascular invasion | 0.000 | |||
Lymph node metastasis | 0.002 | |||
Distant metastasis | 0.111 |
CK19- HCC: Cytokeratin 19 negative hepatocellular carcinoma; CK19+ HCC: Cytokeratin 19 positive hepatocellular carcinoma; cHCC-CC: Combined hepatocellular carcinoma and cholangiocarcinoma; ICC: Intrahepatic cholangiocarcinoma; 95% CI: 95% confidence interval.